# Personalis, Inc.: filings

PSNL · Nasdaq · CIK 1527753 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/psnl.md) · [Financials](/companies/psnl/financials.md) · [Filings](/companies/psnl/filings.md) · [Insiders](/companies/psnl/insiders.md)

## Reports and events: 126 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 259, 8-K 80, 3 23, 10-Q 22, S-8 11, SC 13G/A 11, 144 10, 425 10, CORRESP 10, DEFA14A 8, 10-K 7, 424B5 7, DEF 14A 7, EFFECT 7, SCHEDULE 13G/A 7, UPLOAD 7, S-3 6, SC 13G 6, 4/A 4, ARS 4, D 4, SC 13D/A 3, SCHEDULE 13D/A 3, SC 13D 2, SC 13E3/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 424B4 1, 5 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFM14A 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1, SC 13E3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:05 ET | [8-K](/filings/0001193125-26-415547.md) | 8.01 Other events | 0001193125-26-415547 |
| 2026-08-20 | 20:46 ET | [8-K](/filings/0001193125-26-359300.md) | 8.01 Other events | 0001193125-26-359300 |
| 2026-08-04 | 20:11 ET | [10-Q](/filings/0001193125-26-332817.md) | Quarterly report, period 2026-06-30 | 0001193125-26-332817 |
| 2026-08-04 | 20:04 ET | [8-K](/filings/0001193125-26-332748.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332748 |
| 2026-07-21 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001193125-26-310289.md) | Ownership report, active investor, amended | 0001193125-26-310289 |
| 2026-07-20 | 21:26 ET | [8-K](/filings/0001193125-26-309101.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-309101 |
| 2026-07-20 | 13:18 ET | [8-K](/filings/0001193125-26-308488.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-308488 |
| 2026-06-10 | 00:24 ET | [SCHEDULE 13D/A](/filings/0001805207-26-000003.md) | Ownership report, active investor, amended | 0001805207-26-000003 |
| 2026-05-20 | 20:04 ET | [8-K](/filings/0001193125-26-232533.md) | 8.01 Other events | 0001193125-26-232533 |
| 2026-05-13 | 20:52 ET | [8-K](/filings/0001193125-26-221846.md) | 5.07 Shareholder vote results | 0001193125-26-221846 |
| 2026-05-13 | 20:03 ET | [8-K](/filings/0001193125-26-221574.md) | 8.01 Other events | 0001193125-26-221574 |
| 2026-05-07 | 20:10 ET | [10-Q](/filings/0001193125-26-211896.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211896 |
| 2026-05-07 | 20:03 ET | [8-K](/filings/0001193125-26-211850.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211850 |
| 2026-04-02 | 20:03 ET | [DEF 14A](/filings/0001193125-26-140038.md) | Proxy statement, period 2026-05-12 | 0001193125-26-140038 |
| 2026-03-17 | 20:17 ET | [8-K](/filings/0001193125-26-110852.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-110852 |
| 2026-02-26 | 21:11 ET | [10-K](/filings/0001193125-26-076615.md) | Annual report, period 2025-12-31 | 0001193125-26-076615 |
| 2026-02-26 | 21:05 ET | [8-K](/filings/0001193125-26-076553.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076553 |
| 2026-01-08 | 13:05 ET | [8-K](/filings/0001193125-26-007037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-007037 |
| 2025-11-28 | 22:24 ET | [8-K](/filings/0001193125-25-302644.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-302644 |
| 2025-11-25 | 11:11 ET | [8-K](/filings/0001193125-25-294454.md) | 8.01 Other events | 0001193125-25-294454 |
| 2025-11-10 | 14:11 ET | [8-K](/filings/0001193125-25-273416.md) | 8.01 Other events | 0001193125-25-273416 |
| 2025-11-04 | 21:13 ET | [10-Q](/filings/0001193125-25-264708.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264708 |
| 2025-11-04 | 21:09 ET | [8-K](/filings/0001193125-25-264690.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-264690 |
| 2025-09-12 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001641172-25-027202.md) | Ownership report, active investor, amended | 0001641172-25-027202 |
| 2025-08-22 | 21:55 ET | [8-K](/filings/0000950170-25-110739.md) | 8.01 Other events | 0000950170-25-110739 |
| 2025-08-05 | 20:38 ET | [8-K](/filings/0001193125-25-173575.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-173575 |
| 2025-08-05 | 20:05 ET | [10-Q](/filings/0000950170-25-102993.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102993 |
| 2025-07-09 | 20:17 ET | [8-K](/filings/0001193125-25-157096.md) | 1.01 Entry into a material agreement | 0001193125-25-157096 |
| 2025-05-19 | 20:10 ET | [8-K](/filings/0000950170-25-074346.md) | 5.07 Shareholder vote results | 0000950170-25-074346 |
| 2025-05-06 | 20:24 ET | [10-Q](/filings/0000950170-25-064512.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064512 |
| 2025-05-06 | 20:12 ET | [8-K](/filings/0001193125-25-113820.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-113820 |
| 2025-04-03 | 20:11 ET | [DEF 14A](/filings/0000950170-25-050392.md) | Proxy statement, period 2025-05-16 | 0000950170-25-050392 |
| 2025-02-27 | 22:10 ET | [10-K](/filings/0000950170-25-029221.md) | Annual report, period 2024-12-31 | 0000950170-25-029221 |
| 2025-02-27 | 21:06 ET | [8-K](/filings/0001193125-25-039219.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-039219 |
| 2025-01-07 | 21:36 ET | [8-K](/filings/0001193125-25-002872.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-002872 |
| 2024-12-27 | 21:07 ET | [8-K](/filings/0001193125-24-285922.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-285922 |
| 2024-12-19 | 14:06 ET | [8-K](/filings/0001193125-24-281696.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-281696 |
| 2024-11-06 | 21:10 ET | [10-Q](/filings/0000950170-24-122290.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122290 |
| 2024-11-06 | 21:00 ET | [8-K](/filings/0000950170-24-122230.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122230 |
| 2024-09-19 | 21:28 ET | [8-K](/filings/0000950170-24-108191.md) | 8.01 Other events | 0000950170-24-108191 |
| 2024-08-20 | 16:27 ET | [SC 13D/A](/filings/0001493152-24-033275.md) | Ownership report, active investor, amended | 0001493152-24-033275 |
| 2024-08-16 | 13:25 ET | [8-K](/filings/0001193125-24-201697.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-201697 |
| 2024-08-07 | 20:35 ET | [10-Q](/filings/0000950170-24-092883.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092883 |
| 2024-08-07 | 20:00 ET | [8-K](/filings/0000950170-24-092712.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092712 |
| 2024-07-03 | 13:05 ET | [SC 13D](/filings/0001493152-24-026166.md) | Ownership report, active investor | 0001493152-24-026166 |
| 2024-06-28 | 20:01 ET | [SC 13D/A](/filings/0001140361-24-031739.md) | Ownership report, active investor, amended | 0001140361-24-031739 |
| 2024-06-27 | 21:26 ET | [8-K](/filings/0000950170-24-078618.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-078618 |
| 2024-05-21 | 20:12 ET | [8-K](/filings/0000950170-24-062886.md) | 5.07 Shareholder vote results | 0000950170-24-062886 |
| 2024-05-08 | 20:05 ET | [10-Q](/filings/0000950170-24-055607.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055607 |
| 2024-05-08 | 20:00 ET | [8-K](/filings/0000950170-24-055585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055585 |

Page 1 of 3. [Older](/companies/psnl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.